Literature DB >> 24898057

Signalling: FOXM1 and CENPF: co-pilots driving prostate cancer.

Isabel Lokody.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24898057     DOI： 10.1038/nrc3772

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy.

Authors:  Alvaro Aytes; Antonina Mitrofanova; Celine Lefebvre; Mariano J Alvarez; Mireia Castillo-Martin; Tian Zheng; James A Eastham; Anuradha Gopalan; Kenneth J Pienta; Michael M Shen; Andrea Califano; Cory Abate-Shen
Journal:  Cancer Cell       Date:  2014-05-12       Impact factor: 31.743
  1 in total
  13 in total

1.  Downregulation of CENPF Remodels Prostate Cancer Cells and Alters Cellular Metabolism.

Authors:  Muhammad Shahid; Minhyung Kim; Min Young Lee; Austin Yeon; Sungyong You; Hyung L Kim; Jayoung Kim
Journal:  Proteomics       Date:  2019-05-08       Impact factor: 5.393

2.  Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.

Authors:  Li Peng; Xiu Wu Bian; Di Kang Li; Chuan Xu; Guang Ming Wang; Qing You Xia; Qing Xiong
Journal:  Sci Rep       Date:  2015-08-21       Impact factor: 4.379

3.  Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma.

Authors:  Huiting Su; Bing Li; Lan Zheng; Haixia Wang; Liping Zhang
Journal:  Oncotarget       Date:  2016-07-26

4.  FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription.

Authors:  Youhong Liu; Yijun Liu; Bowen Yuan; Linglong Yin; Yuchong Peng; Xiaohui Yu; Weibing Zhou; Zhicheng Gong; Jianye Liu; Leye He; Xiong Li
Journal:  Oncotarget       Date:  2017-03-07

5.  Expression and functional characterization of FOXM1 in non-small cell lung cancer.

Authors:  Yan Zhang; Wen-Bin Qiao; Li Shan
Journal:  Onco Targets Ther       Date:  2018-06-11       Impact factor: 4.147

6.  Integrated bioinformatics analysis to identify 15 hub genes in breast cancer.

Authors:  Haoxuan Jin; Xiaoyan Huang; Kang Shao; Guibo Li; Jian Wang; Huanming Yang; Yong Hou
Journal:  Oncol Lett       Date:  2019-05-30       Impact factor: 2.967

7.  Altered CELF1 binding to target transcripts in malignant T cells.

Authors:  Paul R Bohjanen; Mai Lee Moua; Liang Guo; Ammanuel Taye; Irina A Vlasova-St Louis
Journal:  RNA       Date:  2015-08-06       Impact factor: 4.942

8.  Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.

Authors:  Ryosuke Matsushita; Hirofumi Yoshino; Hideki Enokida; Yusuke Goto; Kazutaka Miyamoto; Masaya Yonemori; Satoru Inoguchi; Masayuki Nakagawa; Naohiko Seki
Journal:  Oncotarget       Date:  2016-05-10

9.  Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer.

Authors:  Sifeng Qu; Xinpei Ci; Hui Xue; Xin Dong; Jun Hao; Dong Lin; Pier-Luc Clermont; Rebecca Wu; Colin C Collins; Peter W Gout; Yuzhuo Wang
Journal:  Br J Cancer       Date:  2018-01-30       Impact factor: 7.640

10.  Screening and identification of genes associated with cell proliferation in cholangiocarcinoma.

Authors:  Li Guo; Yaodong Zhang; Zibo Yin; Yaya Ji; Guowei Yang; Bowen Qian; Sunjing Li; Jun Wang; Tingming Liang; Changxian Li; Xiangcheng Li
Journal:  Aging (Albany NY)       Date:  2020-02-10       Impact factor: 5.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.